Clinical trial

Radioimmunotherapy With or Without Chemotherapy Plus Peripheral Stem Cell…

NCT00004048 · Garden State Cancer Center at the Center for Molecular Medicine and Immunology, Other · Completed

Key facts

NCT number NCT00004048
Title Radioimmunotherapy With or Without Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Thyroid Cancer
Official title Phase I/II Radioimmunotherapy With High-Dose 90Y-Labeled Humanized MN-14 Alone or Combined With Doxorubicin and Peripheral Blood Stem Cell Rescue (PBSCR) in Medullary Thyroid Cancer (MTC) Grant Application Title: Radioimmunotherapy of MTC With Y-90 Humanized MN14 Anti-CEA Mab and Doxorubicin
Lead sponsor Garden State Cancer Center at the Center for Molecular Medicine and Immunology, Other
Status Completed
Phase Phase 1/Phase 2
Study type Interventional
Conditions Head and Neck Cancer
Intervention type Biological, Drug, Procedure, Radiation
Interventions filgrastim, doxorubicin hydrochloride, autologous bone marrow transplantation, peripheral blood stem cell transplantation, indium In 111 monoclonal antibody MN-14, yttrium Y 90 monoclonal antibody MN-14
Enrollment 30
Start date Sep 1, 1998
Primary completion May 1, 2002
Completion May 1, 2002
First posted Apr 15, 2004
Last update posted Jun 22, 2011
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies